| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | 0.076 | 0.04 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | 0.07 | 0.04 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.05 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.05 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.05 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | -0.21 | 0.05 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.05 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.065 | 0.06 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.06 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.07 |